15 results found.

Hematopoietic/Lymphoid Cancer, Non-hodgkin Lymphoma,B Cell, or Re Clinical Trial using Biological: anti-CD19-CAR vector-transduced T cells genetically engineered lymphocyte therapy

Chinese PLA General Hospital - Recruiting 50 years to 80 years.
- Anti-CD19 Chimeric Antigen Receptor Modified T Cells Infusion in Mantle Cell Lymphoma.
Biological: anti-CD19-CAR vector-transduced T cells genetically engineered lymphocyte therapy

Leukemia, or Lymphoma Clinical Trial using HSCT; DLI

M.D. Anderson Cancer Center - Recruiting 1 year to 65 years.
- CD19-Specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation.
HSCT; DLI

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Clinical Trial using yttrium Y 90 anti-CD45 monoclonal antibody BC8; carmustine; etoposide; cytarabine; melphalan; peripheral blood stem cell transplantation; autologous hematopoietic stem cell transplantation; laboratory biomarker analysis

Fred Hutchinson Cancer Research Center - Recruiting 18 years or older.
- A Phase I/II Study Evaluating Escalating Doses of 90Y-BC8-DOTA (Anti-CD45) Antibody Followed by BEAM Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Lymphoid Malignancies.
yttrium Y 90 anti-CD45 monoclonal antibody BC8; carmustine; etoposide; cytarabine; melphalan; peripheral blood stem cell transplantation; autologous hematopoietic stem cell transplantation; laboratory biomarker analysis

Lymphoma, or B-cell Lymphoma Clinical Trial using Leukapheresis; Stem Cell Transplant; CD19-specific T Cell Infusion; IL-2; Carmustine; Etoposide; Cytarabine; Melphalan; Rituximab

M.D. Anderson Cancer Center - Recruiting 18 years to 65 years.
- CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies After Autologous Hematopoietic Stem Cell Transplantation.
Leukapheresis; Stem Cell Transplant; CD19-specific T Cell Infusion; IL-2; Carmustine; Etoposide; Cytarabine; Melphalan; Rituximab

Hematopoietic/Lymphoid Cancer Clinical Trial using brentuximab vedotin; laboratory biomarker analysis; pharmacological study

Fred Hutchinson Cancer Research Center - Recruiting 12 years to 75 years.
- Maintenance Therapy With Brentuximab Vedotin (SGN-35) After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma and CD30+ Hematologic Malignancies.
brentuximab vedotin; laboratory biomarker analysis; pharmacological study

Blood Cancer, or Leukemia Clinical Trial using cyclosporine; Thymoglobulin; mycophenolate mofetil; g-csf

Stanford University - Recruiting N/A to 70 years.
- Allogeneic Hematopoietic Cell Transplantation Using a Non-Myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Older Patients With Hematologic Malignancies.
cyclosporine; Thymoglobulin; mycophenolate mofetil; g-csf

Myeloproliferative Disorders, Blood Cancer, or Myelodysplastic Sy Clinical Trial using Total Lymphoid Irradiation (TLI); Anti-Thymocyte Globulin as Conditioning (ATG)

Stanford University - Recruiting 49 years to 75 years.
- Total Lymphoid Irradiation and Anti-Thymocyte Globulin as Conditioning for Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for the Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML).
Total Lymphoid Irradiation (TLI); Anti-Thymocyte Globulin as Conditioning (ATG)

Congenital Combined Immunodeficiency, Fungal Infection, Hematopoi Clinical Trial using caspofungin acetate; fluconazole; voriconazole; laboratory biomarker analysis

Children's Oncology Group - Recruiting N/A to 20 years.
- A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT).
caspofungin acetate; fluconazole; voriconazole; laboratory biomarker analysis

Anemia, Hematopoietic/Lymphoid Cancer, Lymphopenia, Neutropenia, Clinical Trial using Allogeneic hematopoietic stem cell transplantation; Peripheral blood stem cell transplantation; Management of therapy complications

Thomas Jefferson University - Recruiting 18 years or older.
- Compassionate Use of the CliniMACSr CD34 Reagent System for Patients Requiring a Post Hematopoietic Stem Cell Transplant Boost of Donor Hematopoietic Stem Cells.
Allogeneic hematopoietic stem cell transplantation; Peripheral blood stem cell transplantation; Management of therapy complications

Hematopoietic/Lymphoid Cancer Clinical Trial using fPER

University of Colorado, Denver - Recruiting 18 years to 75 years.
- Improved Behavioral Outcome in Allogeneic Hematopoietic Stem Cell Transplant Patients by Reducing Caregiver Distress: Behavioral and Physiological Evidence.
fPER

Hematopoietic/Lymphoid Cancer, or Unspecified Adult Solid Tumor, Clinical Trial using questionnaire administration; quality-of-life assessment

City of Hope Medical Center - Recruiting 18 years or older.
- Physical, Emotional and Social Stressors and Their Impact on Quality of Life of Caregivers of Hospitalized Older Adults With Cancer.
questionnaire administration; quality-of-life assessment

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Clinical Trial using iodine I 131 monoclonal antibody BC8; autologous hematopoietic stem cell transplantation; laboratory biomarker analysis

Fred Hutchinson Cancer Research Center - Recruiting 18 years or older.
- A Study Evaluating Escalating Doses of 131I-BC8 (Anti-CD45) Antibody Followed by Autologous Stem Cell Transplantation for Relapsed or Refractory Lymphoid Malignancies.
iodine I 131 monoclonal antibody BC8; autologous hematopoietic stem cell transplantation; laboratory biomarker analysis

Cancer Survivor, Depression, or Hematopoietic/Lymphoid Cancer Clinical Trial using questionnaire administration; survey administration; quality-of-life assessment; internet-based intervention

Fred Hutchinson Cancer Research Center - Recruiting 18 years or older.
- INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-media Program for Long-term Hematopoietic Cell Transplantation Survivors.
questionnaire administration; survey administration; quality-of-life assessment; internet-based intervention

B-cell Chronic Lymphocytic Leukemia, Hematopoietic/Lymphoid Cance Clinical Trial using carfilzomib; Cytokine Assessment; Pharmacodynamic Studies; Proteosome Inhibition Assessment; Pharmacogenomic Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)/Prolymphocytic Leukemia (PLL).
carfilzomib; Cytokine Assessment; Pharmacodynamic Studies; Proteosome Inhibition Assessment; Pharmacogenomic Studies

Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymp Clinical Trial using questionnaire administration; laboratory biomarker analysis

Children's Oncology Group - Recruiting N/A to 21 years.
- Key Adverse Events After Childhood Cancer.
questionnaire administration; laboratory biomarker analysis